SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-21-026670
Filing Date
2021-10-28
Accepted
2021-10-28 21:46:54
Documents
1
Period of Report
2021-10-28

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2365
  Complete submission text file 0001493152-21-026670.txt   3957
Mailing Address HEMMELRATHER WEG 201 LEVERKUSEN 2M D-51377
Business Address HEMMELRATHER WEG 201 LEVERKUSEN 2M D-51377 011 49 214 876 00
Biofrontera AG (Reporting) CIK: 0001712641 (see all company filings)

State of Incorp.: 2M | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40943 | Film No.: 211360418
SIC: 2834 Pharmaceutical Preparations

Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Issuer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations